nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—CYP2C9—brain cancer	0.352	1	CbGaD
Verapamil—ABCC10—Etoposide—brain cancer	0.0794	0.191	CbGbCtD
Verapamil—ABCC3—Etoposide—brain cancer	0.0499	0.12	CbGbCtD
Verapamil—ABCC1—Etoposide—brain cancer	0.0307	0.0736	CbGbCtD
Verapamil—CYP2D6—Lomustine—brain cancer	0.0288	0.0693	CbGbCtD
Verapamil—CYP1A2—Carmustine—brain cancer	0.0285	0.0685	CbGbCtD
Verapamil—ABCC2—Carboplatin—brain cancer	0.027	0.0649	CbGbCtD
Verapamil—ABCG2—Carboplatin—brain cancer	0.0244	0.0587	CbGbCtD
Verapamil—ABCC2—Etoposide—brain cancer	0.0227	0.0545	CbGbCtD
Verapamil—CYP2D6—Hydroxyurea—brain cancer	0.0219	0.0525	CbGbCtD
Verapamil—CYP3A4—Temozolomide—brain cancer	0.0216	0.0518	CbGbCtD
Verapamil—ABCG2—Etoposide—brain cancer	0.0205	0.0493	CbGbCtD
Verapamil—CYP3A4—Lomustine—brain cancer	0.0183	0.044	CbGbCtD
Verapamil—CYP3A5—Etoposide—brain cancer	0.0114	0.0273	CbGbCtD
Verapamil—CYP2C8—Etoposide—brain cancer	0.0109	0.0262	CbGbCtD
Verapamil—CYP1A2—Etoposide—brain cancer	0.00846	0.0203	CbGbCtD
Verapamil—CACNA1A—cerebellar cortex—brain cancer	0.00762	0.0858	CbGeAlD
Verapamil—ABCB1—Etoposide—brain cancer	0.0074	0.0178	CbGbCtD
Verapamil—CYP3A4—Etoposide—brain cancer	0.00443	0.0106	CbGbCtD
Verapamil—CACNA1D—cochlea—brain cancer	0.00327	0.0369	CbGeAlD
Verapamil—CACNA1D—internal ear—brain cancer	0.0031	0.035	CbGeAlD
Verapamil—Distress—Hydroxyurea—brain cancer	0.003	0.0339	CcSEcCtD
Verapamil—CACNB4—ganglion—brain cancer	0.00289	0.0326	CbGeAlD
Verapamil—Hepatotoxicity—Lomustine—brain cancer	0.00219	0.0248	CcSEcCtD
Verapamil—CACNA1A—hindbrain—brain cancer	0.00209	0.0236	CbGeAlD
Verapamil—Emotional distress—Hydroxyurea—brain cancer	0.00196	0.0221	CcSEcCtD
Verapamil—Contusion—Lomustine—brain cancer	0.00194	0.022	CcSEcCtD
Verapamil—Nystagmus—Procarbazine—brain cancer	0.0015	0.017	CcSEcCtD
Verapamil—CACNA1I—telencephalon—brain cancer	0.00135	0.0153	CbGeAlD
Verapamil—Petechiae—Procarbazine—brain cancer	0.00131	0.0148	CcSEcCtD
Verapamil—Lethargy—Lomustine—brain cancer	0.00125	0.0142	CcSEcCtD
Verapamil—CACNA1A—brainstem—brain cancer	0.0012	0.0135	CbGeAlD
Verapamil—CACNB4—telencephalon—brain cancer	0.00111	0.0126	CbGeAlD
Verapamil—Hepatotoxicity—Hydroxyurea—brain cancer	0.00108	0.0122	CcSEcCtD
Verapamil—CACNA1A—telencephalon—brain cancer	0.00106	0.012	CbGeAlD
Verapamil—CACNA1F—head—brain cancer	0.00106	0.0119	CbGeAlD
Verapamil—CACNA1B—telencephalon—brain cancer	0.00104	0.0117	CbGeAlD
Verapamil—SLC22A1—ganglion—brain cancer	0.000972	0.011	CbGeAlD
Verapamil—Gynaecomastia—Procarbazine—brain cancer	0.000962	0.0109	CcSEcCtD
Verapamil—CACNA1G—telencephalon—brain cancer	0.000929	0.0105	CbGeAlD
Verapamil—SLC6A4—ganglion—brain cancer	0.000904	0.0102	CbGeAlD
Verapamil—CACNB1—telencephalon—brain cancer	0.00089	0.01	CbGeAlD
Verapamil—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00088	0.00995	CcSEcCtD
Verapamil—CACNB4—medulla oblongata—brain cancer	0.000876	0.00987	CbGeAlD
Verapamil—Vascular purpura—Procarbazine—brain cancer	0.000872	0.00987	CcSEcCtD
Verapamil—Hepatotoxicity—Carmustine—brain cancer	0.000871	0.00986	CcSEcCtD
Verapamil—Extrapyramidal disorder—Temozolomide—brain cancer	0.000863	0.00977	CcSEcCtD
Verapamil—Cholestasis—Temozolomide—brain cancer	0.000856	0.00968	CcSEcCtD
Verapamil—CACNB3—telencephalon—brain cancer	0.000854	0.00962	CbGeAlD
Verapamil—CACNA1B—pituitary gland—brain cancer	0.000846	0.00953	CbGeAlD
Verapamil—Hepatotoxicity—Temozolomide—brain cancer	0.000842	0.00952	CcSEcCtD
Verapamil—CACNA1A—medulla oblongata—brain cancer	0.000836	0.00942	CbGeAlD
Verapamil—Visual impairment—Lomustine—brain cancer	0.000819	0.00927	CcSEcCtD
Verapamil—CACNA1B—medulla oblongata—brain cancer	0.000816	0.00919	CbGeAlD
Verapamil—Purpura—Procarbazine—brain cancer	0.00081	0.00916	CcSEcCtD
Verapamil—CACNB4—midbrain—brain cancer	0.0008	0.00902	CbGeAlD
Verapamil—Lethargy—Procarbazine—brain cancer	0.000796	0.00901	CcSEcCtD
Verapamil—Petechiae—Temozolomide—brain cancer	0.00079	0.00894	CcSEcCtD
Verapamil—CACNB4—spinal cord—brain cancer	0.000781	0.0088	CbGeAlD
Verapamil—Diplopia—Procarbazine—brain cancer	0.00078	0.00883	CcSEcCtD
Verapamil—Accidental injury—Carmustine—brain cancer	0.00076	0.0086	CcSEcCtD
Verapamil—Rash maculo-papular—Hydroxyurea—brain cancer	0.000756	0.00856	CcSEcCtD
Verapamil—CACNA1I—cerebellum—brain cancer	0.000753	0.00848	CbGeAlD
Verapamil—Alopecia—Lomustine—brain cancer	0.000751	0.0085	CcSEcCtD
Verapamil—CACNA1B—midbrain—brain cancer	0.000746	0.0084	CbGeAlD
Verapamil—Pulmonary oedema—Hydroxyurea—brain cancer	0.00074	0.00838	CcSEcCtD
Verapamil—CACNA1B—spinal cord—brain cancer	0.000728	0.0082	CbGeAlD
Verapamil—CACNB1—medulla oblongata—brain cancer	0.000699	0.00788	CbGeAlD
Verapamil—Laryngospasm—Etoposide—brain cancer	0.000697	0.00788	CcSEcCtD
Verapamil—CACNB3—pituitary gland—brain cancer	0.000695	0.00783	CbGeAlD
Verapamil—CACNB4—head—brain cancer	0.000694	0.00782	CbGeAlD
Verapamil—Hepatic enzyme increased—Temozolomide—brain cancer	0.000687	0.00778	CcSEcCtD
Verapamil—Infection—Carboplatin—brain cancer	0.000686	0.00776	CcSEcCtD
Verapamil—SLC6A4—hindbrain—brain cancer	0.000686	0.00773	CbGeAlD
Verapamil—Hepatotoxicity—Etoposide—brain cancer	0.000673	0.00762	CcSEcCtD
Verapamil—CACNB3—medulla oblongata—brain cancer	0.000671	0.00756	CbGeAlD
Verapamil—CACNA1A—head—brain cancer	0.000663	0.00747	CbGeAlD
Verapamil—Respiratory failure—Temozolomide—brain cancer	0.000662	0.00749	CcSEcCtD
Verapamil—Sweating increased—Procarbazine—brain cancer	0.000657	0.00743	CcSEcCtD
Verapamil—Angina pectoris—Procarbazine—brain cancer	0.000657	0.00743	CcSEcCtD
Verapamil—CACNA1B—head—brain cancer	0.000647	0.00729	CbGeAlD
Verapamil—CACNB1—midbrain—brain cancer	0.000639	0.0072	CbGeAlD
Verapamil—CACNB4—central nervous system—brain cancer	0.000634	0.00714	CbGeAlD
Verapamil—CACNB1—spinal cord—brain cancer	0.000624	0.00703	CbGeAlD
Verapamil—Pollakiuria—Procarbazine—brain cancer	0.000623	0.00705	CcSEcCtD
Verapamil—CACNB4—cerebellum—brain cancer	0.000619	0.00698	CbGeAlD
Verapamil—CACNB3—midbrain—brain cancer	0.000613	0.00691	CbGeAlD
Verapamil—CACNA1I—brain—brain cancer	0.000611	0.00689	CbGeAlD
Verapamil—CACNA1A—central nervous system—brain cancer	0.000605	0.00681	CbGeAlD
Verapamil—Gynaecomastia—Carmustine—brain cancer	0.000602	0.00681	CcSEcCtD
Verapamil—Drowsiness—Procarbazine—brain cancer	0.000601	0.0068	CcSEcCtD
Verapamil—Infection—Lomustine—brain cancer	0.0006	0.00679	CcSEcCtD
Verapamil—CACNA1A—cerebellum—brain cancer	0.000591	0.00666	CbGeAlD
Verapamil—Pain—Carboplatin—brain cancer	0.00059	0.00668	CcSEcCtD
Verapamil—CACNA1B—central nervous system—brain cancer	0.00059	0.00665	CbGeAlD
Verapamil—Jaundice—Procarbazine—brain cancer	0.000586	0.00663	CcSEcCtD
Verapamil—CACNA1G—head—brain cancer	0.000578	0.00651	CbGeAlD
Verapamil—CACNA1B—cerebellum—brain cancer	0.000577	0.0065	CbGeAlD
Verapamil—Sweating—Procarbazine—brain cancer	0.000576	0.00652	CcSEcCtD
Verapamil—CACNB2—telencephalon—brain cancer	0.000574	0.00646	CbGeAlD
Verapamil—CACNB1—head—brain cancer	0.000554	0.00624	CbGeAlD
Verapamil—CACNB3—head—brain cancer	0.000532	0.00599	CbGeAlD
Verapamil—Injury—Carmustine—brain cancer	0.000531	0.00601	CcSEcCtD
Verapamil—CACNA1G—central nervous system—brain cancer	0.000528	0.00595	CbGeAlD
Verapamil—Vascular purpura—Temozolomide—brain cancer	0.000527	0.00597	CcSEcCtD
Verapamil—CACNA1G—cerebellum—brain cancer	0.000516	0.00581	CbGeAlD
Verapamil—CACNA1H—gonad—brain cancer	0.000507	0.00571	CbGeAlD
Verapamil—CACNB1—central nervous system—brain cancer	0.000506	0.0057	CbGeAlD
Verapamil—CACNB4—brain—brain cancer	0.000503	0.00567	CbGeAlD
Verapamil—CACNA1D—telencephalon—brain cancer	0.000501	0.00565	CbGeAlD
Verapamil—Flushing—Procarbazine—brain cancer	0.000501	0.00567	CcSEcCtD
Verapamil—CACNA1H—pituitary gland—brain cancer	0.000495	0.00557	CbGeAlD
Verapamil—CACNB1—cerebellum—brain cancer	0.000495	0.00557	CbGeAlD
Verapamil—Purpura—Temozolomide—brain cancer	0.000489	0.00554	CcSEcCtD
Verapamil—Diplopia—Carmustine—brain cancer	0.000488	0.00552	CcSEcCtD
Verapamil—CACNB3—central nervous system—brain cancer	0.000485	0.00547	CbGeAlD
Verapamil—CACNA1A—brain—brain cancer	0.00048	0.00541	CbGeAlD
Verapamil—Alopecia—Procarbazine—brain cancer	0.000477	0.0054	CcSEcCtD
Verapamil—CACNB3—cerebellum—brain cancer	0.000474	0.00534	CbGeAlD
Verapamil—Rash maculo-papular—Etoposide—brain cancer	0.000473	0.00535	CcSEcCtD
Verapamil—Diplopia—Temozolomide—brain cancer	0.000472	0.00534	CcSEcCtD
Verapamil—CACNA1B—brain—brain cancer	0.000469	0.00528	CbGeAlD
Verapamil—CACNB2—pituitary gland—brain cancer	0.000467	0.00526	CbGeAlD
Verapamil—Drowsiness—Hydroxyurea—brain cancer	0.000465	0.00527	CcSEcCtD
Verapamil—CACNA1C—telencephalon—brain cancer	0.000463	0.00521	CbGeAlD
Verapamil—Tremor—Procarbazine—brain cancer	0.00044	0.00498	CcSEcCtD
Verapamil—Muscular weakness—Carmustine—brain cancer	0.000431	0.00487	CcSEcCtD
Verapamil—CYP2C18—endocrine gland—brain cancer	0.000429	0.00483	CbGeAlD
Verapamil—Syncope—Procarbazine—brain cancer	0.000421	0.00477	CcSEcCtD
Verapamil—CACNA1G—brain—brain cancer	0.000419	0.00472	CbGeAlD
Verapamil—ABCC10—telencephalon—brain cancer	0.000419	0.00472	CbGeAlD
Verapamil—ABCB11—endocrine gland—brain cancer	0.000417	0.0047	CbGeAlD
Verapamil—Muscular weakness—Temozolomide—brain cancer	0.000416	0.00471	CcSEcCtD
Verapamil—Loss of consciousness—Procarbazine—brain cancer	0.000413	0.00467	CcSEcCtD
Verapamil—CACNA1D—pituitary gland—brain cancer	0.000408	0.0046	CbGeAlD
Verapamil—CYP3A7—endocrine gland—brain cancer	0.000408	0.0046	CbGeAlD
Verapamil—Convulsion—Procarbazine—brain cancer	0.000407	0.00461	CcSEcCtD
Verapamil—Hypertension—Procarbazine—brain cancer	0.000406	0.00459	CcSEcCtD
Verapamil—CACNB1—brain—brain cancer	0.000402	0.00453	CbGeAlD
Verapamil—Arthralgia—Procarbazine—brain cancer	0.0004	0.00453	CcSEcCtD
Verapamil—Myalgia—Procarbazine—brain cancer	0.0004	0.00453	CcSEcCtD
Verapamil—Sweating increased—Temozolomide—brain cancer	0.000397	0.00449	CcSEcCtD
Verapamil—SLC6A4—brainstem—brain cancer	0.000393	0.00443	CbGeAlD
Verapamil—Dry mouth—Procarbazine—brain cancer	0.000391	0.00443	CcSEcCtD
Verapamil—Cardiac failure—Etoposide—brain cancer	0.000387	0.00438	CcSEcCtD
Verapamil—Confusional state—Procarbazine—brain cancer	0.000387	0.00438	CcSEcCtD
Verapamil—CACNB3—brain—brain cancer	0.000385	0.00434	CbGeAlD
Verapamil—Vomiting—Lomustine—brain cancer	0.000384	0.00435	CcSEcCtD
Verapamil—Oedema—Procarbazine—brain cancer	0.000383	0.00434	CcSEcCtD
Verapamil—CACNA1H—endocrine gland—brain cancer	0.000383	0.00432	CbGeAlD
Verapamil—Infection—Procarbazine—brain cancer	0.000381	0.00431	CcSEcCtD
Verapamil—Upper respiratory tract infection—Temozolomide—brain cancer	0.000379	0.00429	CcSEcCtD
Verapamil—Shock—Procarbazine—brain cancer	0.000377	0.00427	CcSEcCtD
Verapamil—CACNA1C—pituitary gland—brain cancer	0.000377	0.00425	CbGeAlD
Verapamil—Pollakiuria—Temozolomide—brain cancer	0.000377	0.00426	CcSEcCtD
Verapamil—Erectile dysfunction—Temozolomide—brain cancer	0.000376	0.00425	CcSEcCtD
Verapamil—SLC22A1—telencephalon—brain cancer	0.000375	0.00423	CbGeAlD
Verapamil—Tachycardia—Procarbazine—brain cancer	0.000374	0.00424	CcSEcCtD
Verapamil—Hyperhidrosis—Procarbazine—brain cancer	0.000371	0.0042	CcSEcCtD
Verapamil—Alopecia—Hydroxyurea—brain cancer	0.000369	0.00418	CcSEcCtD
Verapamil—SLCO1A2—telencephalon—brain cancer	0.000361	0.00407	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00036	0.00408	CcSEcCtD
Verapamil—Cardiac arrest—Etoposide—brain cancer	0.000359	0.00406	CcSEcCtD
Verapamil—Nausea—Lomustine—brain cancer	0.000359	0.00406	CcSEcCtD
Verapamil—Hypotension—Procarbazine—brain cancer	0.000358	0.00406	CcSEcCtD
Verapamil—CACNB2—head—brain cancer	0.000357	0.00402	CbGeAlD
Verapamil—ABCC10—gonad—brain cancer	0.00035	0.00394	CbGeAlD
Verapamil—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000349	0.00395	CcSEcCtD
Verapamil—SLC6A4—telencephalon—brain cancer	0.000349	0.00393	CbGeAlD
Verapamil—Insomnia—Procarbazine—brain cancer	0.000347	0.00393	CcSEcCtD
Verapamil—Paraesthesia—Procarbazine—brain cancer	0.000344	0.0039	CcSEcCtD
Verapamil—KCNJ11—endocrine gland—brain cancer	0.000343	0.00387	CbGeAlD
Verapamil—ABCC10—pituitary gland—brain cancer	0.000341	0.00384	CbGeAlD
Verapamil—Sinusitis—Temozolomide—brain cancer	0.000341	0.00386	CcSEcCtD
Verapamil—Somnolence—Procarbazine—brain cancer	0.000341	0.00386	CcSEcCtD
Verapamil—Cramp muscle—Etoposide—brain cancer	0.00034	0.00385	CcSEcCtD
Verapamil—KCNJ11—head—brain cancer	0.000339	0.00382	CbGeAlD
Verapamil—CACNA1H—cerebellum—brain cancer	0.000337	0.0038	CbGeAlD
Verapamil—Hypoaesthesia—Carmustine—brain cancer	0.000336	0.0038	CcSEcCtD
Verapamil—Oedema peripheral—Carmustine—brain cancer	0.000333	0.00376	CcSEcCtD
Verapamil—CYP2D6—hindbrain—brain cancer	0.000331	0.00372	CbGeAlD
Verapamil—Fatigue—Procarbazine—brain cancer	0.000331	0.00374	CcSEcCtD
Verapamil—ABCC10—medulla oblongata—brain cancer	0.000329	0.00371	CbGeAlD
Verapamil—Constipation—Procarbazine—brain cancer	0.000328	0.00371	CcSEcCtD
Verapamil—Pain—Procarbazine—brain cancer	0.000328	0.00371	CcSEcCtD
Verapamil—Hepatitis—Temozolomide—brain cancer	0.000326	0.00369	CcSEcCtD
Verapamil—CACNB2—central nervous system—brain cancer	0.000326	0.00367	CbGeAlD
Verapamil—Visual impairment—Carmustine—brain cancer	0.000325	0.00368	CcSEcCtD
Verapamil—Hypoaesthesia—Temozolomide—brain cancer	0.000325	0.00367	CcSEcCtD
Verapamil—Pharyngitis—Temozolomide—brain cancer	0.000324	0.00367	CcSEcCtD
Verapamil—Oedema peripheral—Temozolomide—brain cancer	0.000321	0.00364	CcSEcCtD
Verapamil—Bronchospasm—Etoposide—brain cancer	0.000321	0.00363	CcSEcCtD
Verapamil—SLC22A4—pituitary gland—brain cancer	0.000321	0.00361	CbGeAlD
Verapamil—CACNB2—cerebellum—brain cancer	0.000319	0.00359	CbGeAlD
Verapamil—Sweating increased—Etoposide—brain cancer	0.000318	0.0036	CcSEcCtD
Verapamil—CACNA1D—endocrine gland—brain cancer	0.000316	0.00356	CbGeAlD
Verapamil—Feeling abnormal—Procarbazine—brain cancer	0.000316	0.00358	CcSEcCtD
Verapamil—Convulsion—Hydroxyurea—brain cancer	0.000315	0.00357	CcSEcCtD
Verapamil—Visual impairment—Temozolomide—brain cancer	0.000315	0.00356	CcSEcCtD
Verapamil—Flushing—Carmustine—brain cancer	0.000313	0.00355	CcSEcCtD
Verapamil—CACNA1D—head—brain cancer	0.000312	0.00352	CbGeAlD
Verapamil—KCNJ11—central nervous system—brain cancer	0.000309	0.00349	CbGeAlD
Verapamil—Erythema multiforme—Temozolomide—brain cancer	0.000309	0.00349	CcSEcCtD
Verapamil—Discomfort—Hydroxyurea—brain cancer	0.000306	0.00346	CcSEcCtD
Verapamil—Urticaria—Procarbazine—brain cancer	0.000305	0.00345	CcSEcCtD
Verapamil—Tinnitus—Temozolomide—brain cancer	0.000304	0.00344	CcSEcCtD
Verapamil—Flushing—Temozolomide—brain cancer	0.000303	0.00343	CcSEcCtD
Verapamil—KCNJ11—cerebellum—brain cancer	0.000302	0.00341	CbGeAlD
Verapamil—ABCC10—midbrain—brain cancer	0.000301	0.00339	CbGeAlD
Verapamil—Alopecia—Carmustine—brain cancer	0.000298	0.00338	CcSEcCtD
Verapamil—Oedema—Hydroxyurea—brain cancer	0.000297	0.00336	CcSEcCtD
Verapamil—ABCC1—telencephalon—brain cancer	0.000296	0.00334	CbGeAlD
Verapamil—Infection—Hydroxyurea—brain cancer	0.000295	0.00334	CcSEcCtD
Verapamil—ABCC10—spinal cord—brain cancer	0.000294	0.00331	CbGeAlD
Verapamil—CACNA1C—endocrine gland—brain cancer	0.000292	0.00329	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000288	0.00326	CcSEcCtD
Verapamil—Alopecia—Temozolomide—brain cancer	0.000288	0.00326	CcSEcCtD
Verapamil—CACNA1C—head—brain cancer	0.000288	0.00325	CbGeAlD
Verapamil—Acute coronary syndrome—Etoposide—brain cancer	0.000287	0.00325	CcSEcCtD
Verapamil—Myocardial infarction—Etoposide—brain cancer	0.000285	0.00323	CcSEcCtD
Verapamil—CACNA1D—central nervous system—brain cancer	0.000285	0.00321	CbGeAlD
Verapamil—SLCO1A2—medulla oblongata—brain cancer	0.000284	0.0032	CbGeAlD
Verapamil—Jaundice—Etoposide—brain cancer	0.000284	0.00321	CcSEcCtD
Verapamil—Hypersensitivity—Procarbazine—brain cancer	0.000283	0.0032	CcSEcCtD
Verapamil—SLCO1B1—endocrine gland—brain cancer	0.00028	0.00315	CbGeAlD
Verapamil—SCN5A—head—brain cancer	0.000279	0.00315	CbGeAlD
Verapamil—CACNA1D—cerebellum—brain cancer	0.000279	0.00314	CbGeAlD
Verapamil—Vision blurred—Carmustine—brain cancer	0.000277	0.00314	CcSEcCtD
Verapamil—SLC22A4—spinal cord—brain cancer	0.000276	0.00311	CbGeAlD
Verapamil—KCNH2—telencephalon—brain cancer	0.000276	0.00311	CbGeAlD
Verapamil—Tremor—Carmustine—brain cancer	0.000275	0.00312	CcSEcCtD
Verapamil—Asthenia—Procarbazine—brain cancer	0.000275	0.00311	CcSEcCtD
Verapamil—CACNA1H—brain—brain cancer	0.000274	0.00309	CbGeAlD
Verapamil—Pruritus—Procarbazine—brain cancer	0.000271	0.00307	CcSEcCtD
Verapamil—Agitation—Carmustine—brain cancer	0.00027	0.00306	CcSEcCtD
Verapamil—Vision blurred—Temozolomide—brain cancer	0.000268	0.00303	CcSEcCtD
Verapamil—Tremor—Temozolomide—brain cancer	0.000266	0.00301	CcSEcCtD
Verapamil—ABCC3—endocrine gland—brain cancer	0.000266	0.00299	CbGeAlD
Verapamil—Dyspnoea—Hydroxyurea—brain cancer	0.000265	0.00299	CcSEcCtD
Verapamil—ABCC10—endocrine gland—brain cancer	0.000264	0.00298	CbGeAlD
Verapamil—Somnolence—Hydroxyurea—brain cancer	0.000264	0.00299	CcSEcCtD
Verapamil—CACNA1C—central nervous system—brain cancer	0.000263	0.00296	CbGeAlD
Verapamil—Diarrhoea—Procarbazine—brain cancer	0.000262	0.00297	CcSEcCtD
Verapamil—ABCC3—head—brain cancer	0.000262	0.00295	CbGeAlD
Verapamil—Dyspepsia—Hydroxyurea—brain cancer	0.000261	0.00296	CcSEcCtD
Verapamil—Agitation—Temozolomide—brain cancer	0.000261	0.00295	CcSEcCtD
Verapamil—Hypoaesthesia—Etoposide—brain cancer	0.00026	0.00294	CcSEcCtD
Verapamil—Angioedema—Temozolomide—brain cancer	0.00026	0.00294	CcSEcCtD
Verapamil—SLCO1A2—midbrain—brain cancer	0.000259	0.00292	CbGeAlD
Verapamil—CACNB2—brain—brain cancer	0.000259	0.00292	CbGeAlD
Verapamil—CACNA1C—cerebellum—brain cancer	0.000257	0.0029	CbGeAlD
Verapamil—Fatigue—Hydroxyurea—brain cancer	0.000256	0.0029	CcSEcCtD
Verapamil—Vertigo—Temozolomide—brain cancer	0.000255	0.00289	CcSEcCtD
Verapamil—SCN5A—central nervous system—brain cancer	0.000255	0.00287	CbGeAlD
Verapamil—Convulsion—Carmustine—brain cancer	0.000255	0.00288	CcSEcCtD
Verapamil—Hypertension—Carmustine—brain cancer	0.000254	0.00287	CcSEcCtD
Verapamil—Constipation—Hydroxyurea—brain cancer	0.000254	0.00287	CcSEcCtD
Verapamil—Pain—Hydroxyurea—brain cancer	0.000254	0.00287	CcSEcCtD
Verapamil—Dizziness—Procarbazine—brain cancer	0.000254	0.00287	CcSEcCtD
Verapamil—SLCO1A2—spinal cord—brain cancer	0.000253	0.00285	CbGeAlD
Verapamil—Palpitations—Temozolomide—brain cancer	0.000251	0.00284	CcSEcCtD
Verapamil—SLC6A4—midbrain—brain cancer	0.000251	0.00282	CbGeAlD
Verapamil—Myalgia—Carmustine—brain cancer	0.00025	0.00283	CcSEcCtD
Verapamil—Chest pain—Carmustine—brain cancer	0.00025	0.00283	CcSEcCtD
Verapamil—ABCB1—blood vessel—brain cancer	0.000249	0.00281	CbGeAlD
Verapamil—Erythema multiforme—Etoposide—brain cancer	0.000247	0.00279	CcSEcCtD
Verapamil—Convulsion—Temozolomide—brain cancer	0.000246	0.00279	CcSEcCtD
Verapamil—KCNJ11—brain—brain cancer	0.000246	0.00277	CbGeAlD
Verapamil—ABCG2—telencephalon—brain cancer	0.000245	0.00276	CbGeAlD
Verapamil—Hypertension—Temozolomide—brain cancer	0.000245	0.00278	CcSEcCtD
Verapamil—Feeling abnormal—Hydroxyurea—brain cancer	0.000245	0.00277	CcSEcCtD
Verapamil—SLC6A4—spinal cord—brain cancer	0.000244	0.00275	CbGeAlD
Verapamil—Vomiting—Procarbazine—brain cancer	0.000244	0.00276	CcSEcCtD
Verapamil—Flushing—Etoposide—brain cancer	0.000242	0.00274	CcSEcCtD
Verapamil—Confusional state—Carmustine—brain cancer	0.000242	0.00274	CcSEcCtD
Verapamil—Arthralgia—Temozolomide—brain cancer	0.000242	0.00274	CcSEcCtD
Verapamil—Myalgia—Temozolomide—brain cancer	0.000242	0.00274	CcSEcCtD
Verapamil—Rash—Procarbazine—brain cancer	0.000242	0.00274	CcSEcCtD
Verapamil—Dermatitis—Procarbazine—brain cancer	0.000242	0.00273	CcSEcCtD
Verapamil—ABCC1—pituitary gland—brain cancer	0.000241	0.00272	CbGeAlD
Verapamil—Headache—Procarbazine—brain cancer	0.00024	0.00272	CcSEcCtD
Verapamil—Oedema—Carmustine—brain cancer	0.00024	0.00272	CcSEcCtD
Verapamil—ABCC3—central nervous system—brain cancer	0.000239	0.0027	CbGeAlD
Verapamil—Discomfort—Temozolomide—brain cancer	0.000239	0.0027	CcSEcCtD
Verapamil—Infection—Carmustine—brain cancer	0.000238	0.0027	CcSEcCtD
Verapamil—SLC22A1—endocrine gland—brain cancer	0.000237	0.00267	CbGeAlD
Verapamil—Dry mouth—Temozolomide—brain cancer	0.000237	0.00268	CcSEcCtD
Verapamil—Tachycardia—Carmustine—brain cancer	0.000234	0.00265	CcSEcCtD
Verapamil—Confusional state—Temozolomide—brain cancer	0.000234	0.00265	CcSEcCtD
Verapamil—SLC22A1—head—brain cancer	0.000234	0.00263	CbGeAlD
Verapamil—ABCC10—cerebellum—brain cancer	0.000233	0.00262	CbGeAlD
Verapamil—Oedema—Temozolomide—brain cancer	0.000232	0.00262	CcSEcCtD
Verapamil—Anaphylactic shock—Temozolomide—brain cancer	0.000232	0.00262	CcSEcCtD
Verapamil—Alopecia—Etoposide—brain cancer	0.000231	0.00261	CcSEcCtD
Verapamil—Infection—Temozolomide—brain cancer	0.00023	0.00261	CcSEcCtD
Verapamil—Nausea—Procarbazine—brain cancer	0.000228	0.00258	CcSEcCtD
Verapamil—SLCO1A2—endocrine gland—brain cancer	0.000228	0.00257	CbGeAlD
Verapamil—CACNA1D—brain—brain cancer	0.000226	0.00255	CbGeAlD
Verapamil—SLCO1A2—head—brain cancer	0.000225	0.00253	CbGeAlD
Verapamil—KCNH2—pituitary gland—brain cancer	0.000225	0.00253	CbGeAlD
Verapamil—Hypotension—Carmustine—brain cancer	0.000224	0.00254	CcSEcCtD
Verapamil—Hyperhidrosis—Temozolomide—brain cancer	0.000224	0.00254	CcSEcCtD
Verapamil—SLC6A4—endocrine gland—brain cancer	0.00022	0.00248	CbGeAlD
Verapamil—ABCC4—endocrine gland—brain cancer	0.000219	0.00247	CbGeAlD
Verapamil—SLC22A4—cerebellum—brain cancer	0.000219	0.00247	CbGeAlD
Verapamil—Hypersensitivity—Hydroxyurea—brain cancer	0.000219	0.00247	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Carmustine—brain cancer	0.000219	0.00247	CcSEcCtD
Verapamil—Muscle spasms—Etoposide—brain cancer	0.000219	0.00247	CcSEcCtD
Verapamil—SLC6A4—head—brain cancer	0.000217	0.00245	CbGeAlD
Verapamil—Insomnia—Carmustine—brain cancer	0.000217	0.00246	CcSEcCtD
Verapamil—KCNH2—medulla oblongata—brain cancer	0.000217	0.00244	CbGeAlD
Verapamil—ABCC4—head—brain cancer	0.000216	0.00244	CbGeAlD
Verapamil—Paraesthesia—Carmustine—brain cancer	0.000215	0.00244	CcSEcCtD
Verapamil—Dyspnoea—Carmustine—brain cancer	0.000214	0.00242	CcSEcCtD
Verapamil—Somnolence—Carmustine—brain cancer	0.000213	0.00241	CcSEcCtD
Verapamil—SLC22A1—central nervous system—brain cancer	0.000213	0.0024	CbGeAlD
Verapamil—Asthenia—Hydroxyurea—brain cancer	0.000213	0.00241	CcSEcCtD
Verapamil—SLC22A5—pituitary gland—brain cancer	0.000212	0.00239	CbGeAlD
Verapamil—ABCC2—endocrine gland—brain cancer	0.000212	0.00239	CbGeAlD
Verapamil—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000211	0.00239	CcSEcCtD
Verapamil—Insomnia—Temozolomide—brain cancer	0.00021	0.00237	CcSEcCtD
Verapamil—CACNA1C—brain—brain cancer	0.000209	0.00235	CbGeAlD
Verapamil—Paraesthesia—Temozolomide—brain cancer	0.000208	0.00236	CcSEcCtD
Verapamil—Dyspnoea—Temozolomide—brain cancer	0.000207	0.00234	CcSEcCtD
Verapamil—Somnolence—Temozolomide—brain cancer	0.000206	0.00233	CcSEcCtD
Verapamil—CYP2C8—pituitary gland—brain cancer	0.000205	0.00231	CbGeAlD
Verapamil—SLCO1A2—central nervous system—brain cancer	0.000205	0.00231	CbGeAlD
Verapamil—Constipation—Carmustine—brain cancer	0.000205	0.00232	CcSEcCtD
Verapamil—Pain—Carmustine—brain cancer	0.000205	0.00232	CcSEcCtD
Verapamil—SLC22A5—medulla oblongata—brain cancer	0.000205	0.00231	CbGeAlD
Verapamil—Vertigo—Etoposide—brain cancer	0.000204	0.00231	CcSEcCtD
Verapamil—Dyspepsia—Temozolomide—brain cancer	0.000204	0.00231	CcSEcCtD
Verapamil—Diarrhoea—Hydroxyurea—brain cancer	0.000203	0.0023	CcSEcCtD
Verapamil—SCN5A—brain—brain cancer	0.000202	0.00228	CbGeAlD
Verapamil—SLCO1A2—cerebellum—brain cancer	0.000201	0.00226	CbGeAlD
Verapamil—Fatigue—Temozolomide—brain cancer	0.0002	0.00226	CcSEcCtD
Verapamil—Loss of consciousness—Etoposide—brain cancer	0.0002	0.00226	CcSEcCtD
Verapamil—ABCG2—pituitary gland—brain cancer	0.0002	0.00225	CbGeAlD
Verapamil—SLC6A4—central nervous system—brain cancer	0.000198	0.00223	CbGeAlD
Verapamil—Pain—Temozolomide—brain cancer	0.000198	0.00224	CcSEcCtD
Verapamil—Constipation—Temozolomide—brain cancer	0.000198	0.00224	CcSEcCtD
Verapamil—KCNH2—midbrain—brain cancer	0.000198	0.00223	CbGeAlD
Verapamil—Feeling abnormal—Carmustine—brain cancer	0.000198	0.00224	CcSEcCtD
Verapamil—ABCC4—central nervous system—brain cancer	0.000198	0.00223	CbGeAlD
Verapamil—Convulsion—Etoposide—brain cancer	0.000197	0.00223	CcSEcCtD
Verapamil—Hypertension—Etoposide—brain cancer	0.000196	0.00222	CcSEcCtD
Verapamil—Dizziness—Hydroxyurea—brain cancer	0.000196	0.00222	CcSEcCtD
Verapamil—Chest pain—Etoposide—brain cancer	0.000194	0.00219	CcSEcCtD
Verapamil—KCNH2—spinal cord—brain cancer	0.000193	0.00218	CbGeAlD
Verapamil—ABCG2—medulla oblongata—brain cancer	0.000193	0.00217	CbGeAlD
Verapamil—Discomfort—Etoposide—brain cancer	0.000191	0.00216	CcSEcCtD
Verapamil—Feeling abnormal—Temozolomide—brain cancer	0.000191	0.00216	CcSEcCtD
Verapamil—ABCC3—brain—brain cancer	0.00019	0.00214	CbGeAlD
Verapamil—CYP2D6—brainstem—brain cancer	0.00019	0.00213	CbGeAlD
Verapamil—ABCC10—brain—brain cancer	0.000189	0.00213	CbGeAlD
Verapamil—CYP2B6—gonad—brain cancer	0.000189	0.00213	CbGeAlD
Verapamil—Vomiting—Hydroxyurea—brain cancer	0.000189	0.00214	CcSEcCtD
Verapamil—SLC22A5—midbrain—brain cancer	0.000187	0.00211	CbGeAlD
Verapamil—Rash—Hydroxyurea—brain cancer	0.000187	0.00212	CcSEcCtD
Verapamil—Confusional state—Etoposide—brain cancer	0.000187	0.00212	CcSEcCtD
Verapamil—Dermatitis—Hydroxyurea—brain cancer	0.000187	0.00212	CcSEcCtD
Verapamil—Headache—Hydroxyurea—brain cancer	0.000186	0.0021	CcSEcCtD
Verapamil—Anaphylactic shock—Etoposide—brain cancer	0.000186	0.0021	CcSEcCtD
Verapamil—Infection—Etoposide—brain cancer	0.000184	0.00209	CcSEcCtD
Verapamil—Urticaria—Temozolomide—brain cancer	0.000184	0.00208	CcSEcCtD
Verapamil—SLC22A5—spinal cord—brain cancer	0.000183	0.00206	CbGeAlD
Verapamil—CYP2C19—endocrine gland—brain cancer	0.000182	0.00205	CbGeAlD
Verapamil—Tachycardia—Etoposide—brain cancer	0.000181	0.00205	CcSEcCtD
Verapamil—Hyperhidrosis—Etoposide—brain cancer	0.000179	0.00203	CcSEcCtD
Verapamil—SLC22A4—brain—brain cancer	0.000178	0.002	CbGeAlD
Verapamil—Hypersensitivity—Carmustine—brain cancer	0.000177	0.002	CcSEcCtD
Verapamil—Nausea—Hydroxyurea—brain cancer	0.000176	0.00199	CcSEcCtD
Verapamil—ABCG2—midbrain—brain cancer	0.000176	0.00198	CbGeAlD
Verapamil—KCNH2—endocrine gland—brain cancer	0.000174	0.00196	CbGeAlD
Verapamil—Hypotension—Etoposide—brain cancer	0.000173	0.00196	CcSEcCtD
Verapamil—Asthenia—Carmustine—brain cancer	0.000172	0.00195	CcSEcCtD
Verapamil—ABCG2—spinal cord—brain cancer	0.000172	0.00194	CbGeAlD
Verapamil—KCNH2—head—brain cancer	0.000172	0.00193	CbGeAlD
Verapamil—Hypersensitivity—Temozolomide—brain cancer	0.000171	0.00193	CcSEcCtD
Verapamil—SLC22A1—brain—brain cancer	0.000169	0.00191	CbGeAlD
Verapamil—CYP2D6—telencephalon—brain cancer	0.000168	0.00189	CbGeAlD
Verapamil—Paraesthesia—Etoposide—brain cancer	0.000167	0.00189	CcSEcCtD
Verapamil—Asthenia—Temozolomide—brain cancer	0.000166	0.00188	CcSEcCtD
Verapamil—Dyspnoea—Etoposide—brain cancer	0.000165	0.00187	CcSEcCtD
Verapamil—Somnolence—Etoposide—brain cancer	0.000165	0.00187	CcSEcCtD
Verapamil—ABCC1—cerebellum—brain cancer	0.000165	0.00185	CbGeAlD
Verapamil—Diarrhoea—Carmustine—brain cancer	0.000164	0.00186	CcSEcCtD
Verapamil—Pruritus—Temozolomide—brain cancer	0.000164	0.00186	CcSEcCtD
Verapamil—SLCO1A2—brain—brain cancer	0.000163	0.00184	CbGeAlD
Verapamil—Fatigue—Etoposide—brain cancer	0.00016	0.00181	CcSEcCtD
Verapamil—CYP2C8—endocrine gland—brain cancer	0.000159	0.00179	CbGeAlD
Verapamil—Dizziness—Carmustine—brain cancer	0.000159	0.0018	CcSEcCtD
Verapamil—Pain—Etoposide—brain cancer	0.000159	0.0018	CcSEcCtD
Verapamil—Constipation—Etoposide—brain cancer	0.000159	0.0018	CcSEcCtD
Verapamil—Diarrhoea—Temozolomide—brain cancer	0.000159	0.0018	CcSEcCtD
Verapamil—SLC6A4—brain—brain cancer	0.000157	0.00177	CbGeAlD
Verapamil—ABCC4—brain—brain cancer	0.000157	0.00177	CbGeAlD
Verapamil—KCNH2—central nervous system—brain cancer	0.000157	0.00177	CbGeAlD
Verapamil—Dizziness—Temozolomide—brain cancer	0.000153	0.00174	CcSEcCtD
Verapamil—KCNH2—cerebellum—brain cancer	0.000153	0.00173	CbGeAlD
Verapamil—Feeling abnormal—Etoposide—brain cancer	0.000153	0.00173	CcSEcCtD
Verapamil—Vomiting—Carmustine—brain cancer	0.000153	0.00173	CcSEcCtD
Verapamil—Rash—Carmustine—brain cancer	0.000151	0.00171	CcSEcCtD
Verapamil—Dermatitis—Carmustine—brain cancer	0.000151	0.00171	CcSEcCtD
Verapamil—Headache—Carmustine—brain cancer	0.00015	0.0017	CcSEcCtD
Verapamil—CYP1A2—endocrine gland—brain cancer	0.000149	0.00168	CbGeAlD
Verapamil—Vomiting—Temozolomide—brain cancer	0.000147	0.00167	CcSEcCtD
Verapamil—Urticaria—Etoposide—brain cancer	0.000147	0.00167	CcSEcCtD
Verapamil—Rash—Temozolomide—brain cancer	0.000146	0.00165	CcSEcCtD
Verapamil—Dermatitis—Temozolomide—brain cancer	0.000146	0.00165	CcSEcCtD
Verapamil—Headache—Temozolomide—brain cancer	0.000145	0.00164	CcSEcCtD
Verapamil—SLC22A5—cerebellum—brain cancer	0.000145	0.00163	CbGeAlD
Verapamil—CYP3A5—endocrine gland—brain cancer	0.000144	0.00162	CbGeAlD
Verapamil—CYP2B6—endocrine gland—brain cancer	0.000143	0.00161	CbGeAlD
Verapamil—Nausea—Carmustine—brain cancer	0.000143	0.00161	CcSEcCtD
Verapamil—CYP2C9—endocrine gland—brain cancer	0.000141	0.00159	CbGeAlD
Verapamil—CYP2B6—head—brain cancer	0.000141	0.00159	CbGeAlD
Verapamil—Nausea—Temozolomide—brain cancer	0.000138	0.00156	CcSEcCtD
Verapamil—Hypersensitivity—Etoposide—brain cancer	0.000137	0.00155	CcSEcCtD
Verapamil—ABCG2—cerebellum—brain cancer	0.000136	0.00154	CbGeAlD
Verapamil—ABCC1—brain—brain cancer	0.000134	0.00151	CbGeAlD
Verapamil—Asthenia—Etoposide—brain cancer	0.000133	0.00151	CcSEcCtD
Verapamil—Pruritus—Etoposide—brain cancer	0.000131	0.00149	CcSEcCtD
Verapamil—CYP2B6—central nervous system—brain cancer	0.000129	0.00145	CbGeAlD
Verapamil—Diarrhoea—Etoposide—brain cancer	0.000127	0.00144	CcSEcCtD
Verapamil—KCNH2—brain—brain cancer	0.000124	0.0014	CbGeAlD
Verapamil—Dizziness—Etoposide—brain cancer	0.000123	0.00139	CcSEcCtD
Verapamil—ABCB1—telencephalon—brain cancer	0.000121	0.00136	CbGeAlD
Verapamil—Vomiting—Etoposide—brain cancer	0.000118	0.00133	CcSEcCtD
Verapamil—SLC22A5—brain—brain cancer	0.000118	0.00132	CbGeAlD
Verapamil—Rash—Etoposide—brain cancer	0.000117	0.00132	CcSEcCtD
Verapamil—Dermatitis—Etoposide—brain cancer	0.000117	0.00132	CcSEcCtD
Verapamil—Headache—Etoposide—brain cancer	0.000116	0.00132	CcSEcCtD
Verapamil—CYP2C8—brain—brain cancer	0.000114	0.00128	CbGeAlD
Verapamil—ABCG2—brain—brain cancer	0.000111	0.00125	CbGeAlD
Verapamil—Nausea—Etoposide—brain cancer	0.00011	0.00125	CcSEcCtD
Verapamil—CYP3A4—endocrine gland—brain cancer	0.000108	0.00121	CbGeAlD
Verapamil—CYP2D6—endocrine gland—brain cancer	0.000106	0.0012	CbGeAlD
Verapamil—CYP2D6—head—brain cancer	0.000105	0.00118	CbGeAlD
Verapamil—CYP2B6—brain—brain cancer	0.000102	0.00115	CbGeAlD
Verapamil—ABCB1—gonad—brain cancer	0.000101	0.00114	CbGeAlD
Verapamil—ABCB1—pituitary gland—brain cancer	9.85e-05	0.00111	CbGeAlD
Verapamil—CYP3A4—central nervous system—brain cancer	9.71e-05	0.00109	CbGeAlD
Verapamil—CYP2D6—central nervous system—brain cancer	9.56e-05	0.00108	CbGeAlD
Verapamil—ABCB1—medulla oblongata—brain cancer	9.51e-05	0.00107	CbGeAlD
Verapamil—CYP2D6—cerebellum—brain cancer	9.34e-05	0.00105	CbGeAlD
Verapamil—ABCB1—midbrain—brain cancer	8.69e-05	0.000979	CbGeAlD
Verapamil—ABCB1—spinal cord—brain cancer	8.48e-05	0.000955	CbGeAlD
Verapamil—ABCB1—endocrine gland—brain cancer	7.63e-05	0.00086	CbGeAlD
Verapamil—CYP2D6—brain—brain cancer	7.59e-05	0.000855	CbGeAlD
Verapamil—ABCB1—head—brain cancer	7.53e-05	0.000849	CbGeAlD
Verapamil—ABCB1—central nervous system—brain cancer	6.88e-05	0.000775	CbGeAlD
Verapamil—ABCB1—cerebellum—brain cancer	6.72e-05	0.000757	CbGeAlD
Verapamil—ABCB1—brain—brain cancer	5.46e-05	0.000615	CbGeAlD
Verapamil—CACNA1I—Developmental Biology—STAT3—brain cancer	3.15e-05	0.000583	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HES1—brain cancer	3.15e-05	0.000583	CbGpPWpGaD
Verapamil—ABCC1—Disease—HES5—brain cancer	3.14e-05	0.000582	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HES1—brain cancer	3.11e-05	0.000576	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CYP2C9—brain cancer	3.09e-05	0.000572	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—CTNNB1—brain cancer	3.07e-05	0.000569	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—RELA—brain cancer	3.06e-05	0.000567	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.05e-05	0.000565	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—EGFR—brain cancer	3.04e-05	0.000564	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—ERBB2—brain cancer	3.04e-05	0.000564	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—IDH1—brain cancer	3.03e-05	0.000561	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—ERBB2—brain cancer	3.01e-05	0.000557	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VAV1—brain cancer	2.99e-05	0.000554	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—CTNNB1—brain cancer	2.99e-05	0.000553	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.97e-05	0.00055	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.97e-05	0.000549	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—RELA—brain cancer	2.97e-05	0.000549	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—EGFR—brain cancer	2.96e-05	0.000548	CbGpPWpGaD
Verapamil—ABCC4—Ectoderm Differentiation—MYC—brain cancer	2.96e-05	0.000547	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—ERBB2—brain cancer	2.95e-05	0.000546	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—CDK4—brain cancer	2.93e-05	0.000543	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—BSG—brain cancer	2.93e-05	0.000543	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.91e-05	0.00054	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—IDH1—brain cancer	2.89e-05	0.000535	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.88e-05	0.000533	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.88e-05	0.000533	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—IDH1—brain cancer	2.87e-05	0.000531	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.86e-05	0.00053	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—EGFR—brain cancer	2.86e-05	0.00053	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—EGFR—brain cancer	2.86e-05	0.00053	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—ERBB2—brain cancer	2.85e-05	0.000527	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CDK4—brain cancer	2.78e-05	0.000515	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—BSG—brain cancer	2.74e-05	0.000507	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.74e-05	0.000507	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—VEGFA—brain cancer	2.7e-05	0.000501	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—BSG—brain cancer	2.7e-05	0.0005	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—VEGFA—brain cancer	2.7e-05	0.0005	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CYP2C9—brain cancer	2.69e-05	0.000498	CbGpPWpGaD
Verapamil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.68e-05	0.000497	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—STAT3—brain cancer	2.68e-05	0.000496	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—CTNNB1—brain cancer	2.66e-05	0.000493	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.65e-05	0.000491	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—VEGFA—brain cancer	2.63e-05	0.000487	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—BSG—brain cancer	2.63e-05	0.000486	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—STAT3—brain cancer	2.61e-05	0.000482	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	2.59e-05	0.00048	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—CTNNB1—brain cancer	2.58e-05	0.000478	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.53e-05	0.000469	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—ERBB2—brain cancer	2.53e-05	0.000468	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—IDH1—brain cancer	2.52e-05	0.000467	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—RELA—brain cancer	2.52e-05	0.000466	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—ERBB2—brain cancer	2.5e-05	0.000463	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—ERBB2—brain cancer	2.5e-05	0.000463	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CDK4—brain cancer	2.47e-05	0.000457	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.45e-05	0.000453	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CDK4—brain cancer	2.44e-05	0.000452	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—EGFR—brain cancer	2.43e-05	0.000451	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—EGFR—brain cancer	2.43e-05	0.00045	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP2C9—brain cancer	2.42e-05	0.000448	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ENO2—brain cancer	2.4e-05	0.000443	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—EGFR—brain cancer	2.37e-05	0.000438	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—IDH1—brain cancer	2.36e-05	0.000436	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.35e-05	0.000435	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—VEGFA—brain cancer	2.35e-05	0.000434	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—IL2—brain cancer	2.34e-05	0.000434	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.34e-05	0.000433	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—IDH1—brain cancer	2.32e-05	0.00043	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—STAT3—brain cancer	2.32e-05	0.00043	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—VEGFA—brain cancer	2.32e-05	0.000429	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.31e-05	0.000427	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP2C9—brain cancer	2.3e-05	0.000426	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.3e-05	0.000425	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—BSG—brain cancer	2.29e-05	0.000424	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ENO2—brain cancer	2.29e-05	0.000423	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.28e-05	0.000422	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—VEGFA—brain cancer	2.27e-05	0.00042	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ENO2—brain cancer	2.27e-05	0.00042	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—IDH1—brain cancer	2.26e-05	0.000418	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.25e-05	0.000417	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—STAT3—brain cancer	2.25e-05	0.000416	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.2e-05	0.000408	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.2e-05	0.000408	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.2e-05	0.000408	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—VEGFA—brain cancer	2.19e-05	0.000406	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—CTNNB1—brain cancer	2.19e-05	0.000405	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.17e-05	0.000402	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—RELA—brain cancer	2.16e-05	0.0004	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—ERBB2—brain cancer	2.15e-05	0.000397	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP2C9—brain cancer	2.13e-05	0.000394	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.12e-05	0.000392	CbGpPWpGaD
Verapamil—ABCC1—Disease—IDH1—brain cancer	2.11e-05	0.000391	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP2C9—brain cancer	2.11e-05	0.000391	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—EGFR—brain cancer	2.11e-05	0.000391	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—EGFR—brain cancer	2.08e-05	0.000386	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.06e-05	0.000382	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—BSG—brain cancer	2.06e-05	0.000381	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—RELA—brain cancer	2.04e-05	0.000378	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—EGFR—brain cancer	2.04e-05	0.000378	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—ERBB2—brain cancer	2.03e-05	0.000376	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.02e-05	0.000374	CbGpPWpGaD
Verapamil—ABCC1—Disease—HEY1—brain cancer	2e-05	0.000371	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ENO2—brain cancer	1.99e-05	0.000369	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.99e-05	0.000368	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—EGFR—brain cancer	1.97e-05	0.000365	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—IDH1—brain cancer	1.97e-05	0.000364	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP2C9—brain cancer	1.97e-05	0.000364	CbGpPWpGaD
Verapamil—ABCC1—Disease—DLL1—brain cancer	1.97e-05	0.000364	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—BSG—brain cancer	1.96e-05	0.000362	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—VEGFA—brain cancer	1.95e-05	0.000361	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.94e-05	0.000359	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—VEGFA—brain cancer	1.93e-05	0.000357	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—VEGFA—brain cancer	1.93e-05	0.000357	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.92e-05	0.000355	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PIK3CG—brain cancer	1.91e-05	0.000354	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—STAT3—brain cancer	1.91e-05	0.000353	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—PIK3CG—brain cancer	1.9e-05	0.000352	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—brain cancer	1.88e-05	0.000348	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—CTNNB1—brain cancer	1.88e-05	0.000347	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ENO2—brain cancer	1.86e-05	0.000345	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.84e-05	0.000341	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ENO2—brain cancer	1.84e-05	0.00034	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—RELA—brain cancer	1.82e-05	0.000336	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—BSG—brain cancer	1.81e-05	0.000335	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—ERBB2—brain cancer	1.8e-05	0.000334	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PIK3CG—brain cancer	1.8e-05	0.000333	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—RELA—brain cancer	1.8e-05	0.000333	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—BSG—brain cancer	1.8e-05	0.000332	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ENO2—brain cancer	1.79e-05	0.000331	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—ERBB2—brain cancer	1.78e-05	0.00033	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CTNNB1—brain cancer	1.78e-05	0.000329	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—IDH1—brain cancer	1.77e-05	0.000328	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.77e-05	0.000327	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—EGFR—brain cancer	1.75e-05	0.000324	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.74e-05	0.000323	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—EGFR—brain cancer	1.73e-05	0.000321	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—EGFR—brain cancer	1.73e-05	0.000321	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—IDH1—brain cancer	1.68e-05	0.000311	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—BSG—brain cancer	1.67e-05	0.000309	CbGpPWpGaD
Verapamil—ABCC1—Disease—ENO2—brain cancer	1.67e-05	0.000309	CbGpPWpGaD
Verapamil—ABCC1—Disease—SHH—brain cancer	1.67e-05	0.000309	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—VEGFA—brain cancer	1.65e-05	0.000306	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.64e-05	0.000304	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—STAT3—brain cancer	1.64e-05	0.000303	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.6e-05	0.000297	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CTNNB1—brain cancer	1.58e-05	0.000292	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—VEGFA—brain cancer	1.56e-05	0.00029	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CTNNB1—brain cancer	1.56e-05	0.000289	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP2C9—brain cancer	1.56e-05	0.000289	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—IDH1—brain cancer	1.56e-05	0.000288	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ENO2—brain cancer	1.56e-05	0.000288	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—STAT3—brain cancer	1.55e-05	0.000287	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—IDH1—brain cancer	1.54e-05	0.000286	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP2C9—brain cancer	1.53e-05	0.000283	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.51e-05	0.000279	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—EGFR—brain cancer	1.49e-05	0.000275	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.44e-05	0.000267	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—IDH1—brain cancer	1.44e-05	0.000266	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—EGFR—brain cancer	1.41e-05	0.000261	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ENO2—brain cancer	1.4e-05	0.000259	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—VEGFA—brain cancer	1.39e-05	0.000257	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—STAT3—brain cancer	1.38e-05	0.000255	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—VEGFA—brain cancer	1.37e-05	0.000255	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.37e-05	0.000254	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.37e-05	0.000254	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—STAT3—brain cancer	1.36e-05	0.000252	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—IL2—brain cancer	1.34e-05	0.000248	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ENO2—brain cancer	1.33e-05	0.000246	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—BSG—brain cancer	1.33e-05	0.000246	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP2C9—brain cancer	1.32e-05	0.000245	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—BSG—brain cancer	1.3e-05	0.00024	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.28e-05	0.000236	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—EGFR—brain cancer	1.25e-05	0.000232	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—EGFR—brain cancer	1.24e-05	0.000229	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ENO2—brain cancer	1.23e-05	0.000228	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ENO2—brain cancer	1.22e-05	0.000226	CbGpPWpGaD
Verapamil—ABCC1—Disease—VAV1—brain cancer	1.21e-05	0.000223	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP2C9—brain cancer	1.18e-05	0.000218	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP2C9—brain cancer	1.15e-05	0.000213	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—IDH1—brain cancer	1.14e-05	0.000211	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—brain cancer	1.14e-05	0.00021	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ENO2—brain cancer	1.14e-05	0.00021	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.13e-05	0.000209	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—BSG—brain cancer	1.12e-05	0.000208	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—IDH1—brain cancer	1.12e-05	0.000207	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.12e-05	0.000207	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CG—brain cancer	1.1e-05	0.000203	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP2C9—brain cancer	1.09e-05	0.000201	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CG—brain cancer	1.05e-05	0.000194	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CG—brain cancer	1.04e-05	0.000193	CbGpPWpGaD
Verapamil—ABCC1—Disease—HES1—brain cancer	1.04e-05	0.000192	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—BSG—brain cancer	1e-05	0.000186	CbGpPWpGaD
Verapamil—ABCC1—Disease—PDGFRA—brain cancer	9.89e-06	0.000183	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.82e-06	0.000182	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—BSG—brain cancer	9.79e-06	0.000181	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—IDH1—brain cancer	9.67e-06	0.000179	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—BSG—brain cancer	9.23e-06	0.000171	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP2C9—brain cancer	9.19e-06	0.00017	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—BSG—brain cancer	9.15e-06	0.000169	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CG—brain cancer	9.14e-06	0.000169	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.04e-06	0.000167	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ENO2—brain cancer	9.03e-06	0.000167	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.84e-06	0.000164	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ENO2—brain cancer	8.82e-06	0.000163	CbGpPWpGaD
Verapamil—ABCC1—Disease—IRS2—brain cancer	8.68e-06	0.000161	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—IDH1—brain cancer	8.63e-06	0.00016	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—brain cancer	8.58e-06	0.000159	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CG—brain cancer	8.55e-06	0.000158	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—IDH1—brain cancer	8.42e-06	0.000156	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CG—brain cancer	8.42e-06	0.000156	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CG—brain cancer	8.19e-06	0.000152	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—IDH1—brain cancer	7.94e-06	0.000147	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.87e-06	0.000146	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—IDH1—brain cancer	7.87e-06	0.000146	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—BSG—brain cancer	7.82e-06	0.000145	CbGpPWpGaD
Verapamil—ABCC1—Disease—APC—brain cancer	7.67e-06	0.000142	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ENO2—brain cancer	7.64e-06	0.000141	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.42e-06	0.000137	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CG—brain cancer	7.13e-06	0.000132	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP2C9—brain cancer	7.1e-06	0.000131	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.03e-06	0.00013	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ENO2—brain cancer	6.82e-06	0.000126	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—IDH1—brain cancer	6.72e-06	0.000124	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ENO2—brain cancer	6.66e-06	0.000123	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CG—brain cancer	6.42e-06	0.000119	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.41e-06	0.000119	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ENO2—brain cancer	6.27e-06	0.000116	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ENO2—brain cancer	6.22e-06	0.000115	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CG—brain cancer	6.1e-06	0.000113	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—BSG—brain cancer	6.03e-06	0.000112	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB2—brain cancer	5.95e-06	0.00011	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CG—brain cancer	5.65e-06	0.000105	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CG—brain cancer	5.6e-06	0.000104	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.47e-06	0.000101	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ENO2—brain cancer	5.31e-06	9.84e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CG—brain cancer	5.21e-06	9.65e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—brain cancer	5.21e-06	9.64e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—IDH1—brain cancer	5.19e-06	9.61e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—brain cancer	4.54e-06	8.4e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—brain cancer	4.22e-06	7.81e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CG—brain cancer	4.14e-06	7.67e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—brain cancer	4.13e-06	7.64e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ENO2—brain cancer	4.1e-06	7.59e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CG—brain cancer	4.05e-06	7.49e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CG—brain cancer	3.51e-06	6.49e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CG—brain cancer	3.13e-06	5.79e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CG—brain cancer	3.05e-06	5.65e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CG—brain cancer	2.88e-06	5.33e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CG—brain cancer	2.85e-06	5.28e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CG—brain cancer	2.44e-06	4.51e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CG—brain cancer	1.88e-06	3.48e-05	CbGpPWpGaD
